Task: Answer Verification
Input (English): Question: Are between subjects variability in haemoglobin and dose associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis : a meta-analysis?
Answer: Between subject variability in haemoglobin and ESA dose in dialysis patients is not associated with the type of ESA, nor with the dosing interval or route of administration, except for higher dose requirements in PEG-EPO monthly administration relative to every 2 weeks or rHuEPO i.v. relative to s.c.
Output (English): no